4th UpDate on Hepatology Course Bucharest 2017, Romania 6 th - 7 th April 2017 Bucharest - Crowne Plaza Hotel Hepatology 2017 A panoramic view" Liana GHEORGHE Course Directors Ioan SPOREA Anca TRIFAN
4 th UpDate on Hepatology Course, Bucharest 6 th -7 th April 2017 Hepatology 2017 A panoramic view" 6 April 2017 8.00-9.45 Registration & Welcome 9.50-10.00 Introduction: Liana Gheorghe 10.00-11.30 Challenging issues in hepatitis B Chair: Pietro Lampertico, Mircea Diculescu 10.00-10.25 How to manage HBV infected patients in 2017? Pietro Lampertico, Milan, Italy 10.25-10.45 Hepatitis B reactivation prevention and therapy Adrian Goldiş, Timişoara, România 10.45-11.05 Long-term impact of antiviral therapy in chronic hepatitis B Marcel Tanţău, Cluj-Napoca, România 11.05-11.30 Recent advances in HDV therapy Jerzy Jaroszewicz, Bialystok, Poland 11.30-13.00 Alcoholic and non-alcoholic liver disease Chair: Vlad Ratziu 11.30-11.50 Old and new biomarkers for NASH Mona Munteanu, Paris, France 11.50-12.15 The impact of new multi-parametric measures of fatty liver by ultrasound and magnetic resonance in clinical practice Ferrucio Bonino, Pisa, Italy 12.15-12.35 What is the current medical management of NASH and future perspectives Ioan Sporea, Timişoara, România 12.35-13.00 Treatment of alcoholic hepatitis Vlad Ratziu, Paris, France 13.00-13.30 Satellite Symposium BMS Speaker: Pietro Lampertico, Milan, Italy 13.30-14.30 Lunch
14.30-16.00 Challenging issues in hepatitis C Chair: Nancy Reau, Ioan Sporea 14.30-14.50 HCV treatment of GT-1 patients now and in the future. Strategies for simplification Liana Gheorghe, Bucharest, România 14.50-15.15 Treatment of HCV special populations: decompensated cirrhosis and chronic kidney disease Susanne Beckebaum, Muenster, Germany 15.15-15.40 Impact of therapy on hepatic and extrahepatic manifestation of chronic HCV infection Nancy Reau, Chicago, USA 15.40-16.00 Hepatocellular carcinoma in patients with HCV liver cirrhosis treated with direct-acting antivirals (DAAs) Speranţa Iacob, Bucharest, România 16.00-16.30 Coffee Break and Poster Viewing 16.30-17.30 Satellite Symposium AbbVie 17.30-18.30 Parallel Case-based Workshops 1. Susanne Beckebaum, Speranţa Iacob: Management of chronic hepatitis C 2. Cristian Gheorghe, Carol Stanciu: Special issues in liver cirrhosis 3. Ioan Sporea, Vlad Ratziu: Alcoholic & non-alcoholic fatty liver disease 18.30 Dinner 7 April 2017 8.30-10.30 Hepatocellular carcinoma Chair: Patrizia Burra 8.30-8.50 Combination and dynamics of serum biomarkers to personalized surveillance, diagnosis and management of hepatocellular carcinoma Maurizia Brunetto, Pisa, Italy 8.50-9.10 Diagnosis of hepatocellular carcinoma by imaging : How can we improve accuracy? Ioana Lupescu, Bucharest, România 9.10-9.30 Radiofrequency ablation: who should be treated, how to be done and response evaluation Zeno Spârchez, Cluj-Napoca, România
q 9.30-9.50 Transarterial chemoembolization: who should be treated, how to be done and response evaluation Mugur Grasu, Bucharest, România 9.50-10.10 Transplantation for hepatocellular carcinoma Patrizia Burra, Padova, Italy 10.10-10.30 Systemic therapy and immunotherapy for advanced hepatocellular carcinoma Markus Peck-Radosavljevic, Austria 10.30-11.00 Coffee Break and Poster Viewing 11.00-12.00 Special issues in cirrhosis Chair: Vito Cicinnati, Cristian Gheorghe 11.00-11.20 Acute on chronic liver disease Anca Trifan, Iaşi, România 11.20-11.40 Use of betablockers in decompensated cirrhosis Cristina Cijevschi, Cătălina Mihai, Iaşi, România 11.40-12.00 Cirrhotic coagulopathy: practical aspects Dana Tomescu, Bucharest, România 12.00-13.00 q Satellite Symposium MSD 13.00-14.00 Lunch q 14.00-15.00 Satellite Symposium Gilead 15.00-16.30 Original Research Forum Chair: Costică Aloman, Răzvan Iacob 15.00-15.20 Arguments for hepatocyte reprogramming during advanced liver fibrosis background for hepatocarcinogenesis Răzvan Iacob, Bucharest, România 15.20-15.40 Targeting mononuclear phagocytes development in alcoholic liver injury: pathological and immunological pathways Costică Aloman, Chicago, USA 15.40-15.55 The metabolic profile of decompensation in patients with cirrhosis Bogdan Procopeţ, Cluj-Napoca, România
15.55-16.10 The role of combined liver and spleen elastometry for the prediction of the response to therapy in severe alcoholic hepatitis Horia Ştefănescu, Cluj-Napoca, România 16.10-16.30 Early-TIPS improves survival in high-risk variceal bleeders Results of a multicenter variceal bleeding observational study Virginia Hernandez Gea, Barcelona, Spain 16.30-17.00 Coffee Break q 17.00-17.30 Satellite Symposium Alfa Wassermann Gut Dysbiosis and Inflammation in Cirrhosis and Hepatic Encephalopathy: Role for Microbiota-directed Therapies Speaker: Carmelo Scarpignato, Parma, Italy 17.30-18.30 Autoimmune and genetic liver disease Chair: Susanne Beckebaum, Carol Stanciu 17.30-17.50 Management of autoimmune liver disease in 2017 Vito Cicinnati, Muenster, Germany 17.50-18.10 Management of cholestatic liver diseases in 2017 Iulia Simionov, Bucharest, România 18.10-18.30 Wilson disease: from genetics to therapy Hartmut Schmidt, Muenster, Germany 18.30 Closing and Poster Awards